Patients should inform their healthcare providers about any kidney disease, significant weight changes, or other medications they are taking, as these factors may influence both the therapeutic effects and elimination timeline of GLP-1 receptor agonists
1 However, recent randomised controlled trials (RCTs) have demonstrated the efficacy of some GLP-1 RAs for weight reduction in adults even without diabetes, leading to semaglutide and liraglutide approval as adjuncts to a calorie-restricted diet and exercise for weight management.2, 3, 4 Tirzepatide, a newer dual receptor agonist, has also been demonstrated to induce greater weight reductions, 5 and has recently been approved for patients without diabetes in some countries
Research studies on MTHFR C677T or A1298C variants: Having an MTHFR variant increases the relative risk (not certainty!) of many chronic diseases, but this does not mean it will cause you to have that disease
Zooki Liposomal Glutathione x Holland & Barrett - nationwide store launch No longer just a TikTok sensation, we're thrilled to announce that our Liposomal Glutathione capsules are now stocked in Holland & Barrett stores nationwide in the UK
Ketamine ameliorates depressive-like behaviors in mice through increasing glucose uptake regulated by the ERK/GLUT3 signaling pathway